Desirable performance standards for HbA1c analysis - Precision, accuracy and standardisation: Consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA)

Abstract

Background: HbA1c (glycohaemoglobin) is universally used in the ongoing monitoring of all patients with diabetes. There are many % HbA 1c target control rating recommendations by national, regional and international expert bodies for diabetes patients and these are variable around the world. General patient target control ratings are currently most often recommended as either <6.5% or <7.0% HbA1c, with <6.0% HbA1c stated for individual patients where clinically possible. This necessitates very precise HbA1c assays and the same patient values, irrespective of HbA1c method or area of the world. Methods: HbA 1c targets recommended by major expert groups and published HbA 1c assay precision (coe..